New York-based Colgate-Palmolive Company (CL) manufactures and sells consumer products in the United States and internationally. The company has a market cap of $78.5 billion and operates through two segments: Oral, Personal and Home Care; and Pet Nutrition, and offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, and other products.
CL shares have rallied the broader market over the past year, surging 30.1% compared to the S&P 500 Index’s ($SPX) 13.5% surge. However, in 2026, the stock has grown by nearly 26.6%, outperforming the SPX’s 12.3% rise.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Focusing on its industry benchmark, the State Street Consumer Staples Select Sector SPDR ETF (XLP) has risen 21% over the past year, underperforming the stock. In 2026, XLP has grown 18.4% and has also lagged behind the stock.
www.barchart.com On Oct. 30, CL stock rose 2.3% following the release of its Q3 2026 earnings. The company’s revenue for the quarter rose 4.6% from the prior year’s quarter to $5.4 billion and surpassed the Street’s estimates. Moreover, its adjusted EPS amounted to $0.97, also topping the consensus estimates. Additionally, CL also reported growth in its sales volumes and organic revenue, indicating a robust demand for its products.
For the current year, which ends in December, analysts expect CL’s EPS to rise 6% to $3.91 on a diluted basis. The company surpassed the consensus estimate in each of the last four quarters.
Among the 22 analysts covering CL stock, the consensus is a “Moderate Buy.” That’s based on 10 “Strong Buy” ratings, three “Moderate Buys,” eight “Holds,” and one “Strong Sell.”
www.barchart.com The configuration has remained unchanged for the past months.
On Nov. 4, Barclays analyst Lauren Lieberman maintained a “Hold” rating on Colgate-Palmolive and set a price target of $95.
CL’s mean price target of $100.52 is below the current market price. Its Street-high target of $112 implies a robust 11.4% upside from current levels.
On the date of publication, Aritra Gangopadhyay did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Dear Oklo Stock Fans, Mark Your Calendars for November 6 Dear Future Agility Robotics Stock Investors, Mark Your Calendars for November 5 A $650 Million Reason Why Kraft Heinz Stock Is Up Why It’s Time to Buy the Pullback in Dell Stock